Johnson & White Wealth Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
Johnson & White Wealth Management's ABBV Position: Q3 2026 in Review
Johnson & White Wealth Management reduced its AbbVie (ABBV) stake by 1.2% in Q3 2026, selling an estimated $14.9K and leaving 4,702 shares worth $1.23M. The position accounts for 0.45% of the portfolio, ranked #50.
Johnson & White Wealth Management first reported a position in ABBV in Q3 2022 and has held it in 16 quarters since. 2,874 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- Johnson & White Wealth Management held 4,702 shares of AbbVie worth $1.23M as of Q3 2026.
- Johnson & White Wealth Management sold 58 AbbVie shares in Q3 2026, an estimated $14.9K.
- AbbVie made up 0.45% of Johnson & White Wealth Management's portfolio in Q3 2026, its #50 holding.
- Johnson & White Wealth Management first reported a position in AbbVie in Q3 2022 and has held it in 16 quarters since.
- 2,874 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on Johnson & White Wealth Management's 13F filing for Q3 2026, filed 3 Nov 2026.